Get the Daily Brief

All action, no filler. BioBriefs delivers biotech’s 10 must-know updates, every morning.

Latest Biotech News

Healthcare Policy and Access Innovations

July 13, 2025

Legislation introduced seeks to extend Medicare’s hospital-at-home reimbursement waiver through 2030, reinforcing the model’s role in reducing mortality and costs by enabling acute care in...

Proteomic Study Exposes New Protein Targets in Alzheimer’s

July 13, 2025

Researchers at Johns Hopkins University have used limited proteolysis mass spectrometry (LiP-MS) to uncover over 200 misfolded proteins potentially linked to age-related cognitive decline in a rat...

FDA Rejects Capricor’s Duchenne Cell Therapy Amid Data Gaps

July 13, 2025

Capricor Therapeutics received a complete response letter (CRL) from the FDA rejecting its biologics license application for deramiocel, an off-the-shelf cell therapy targeting cardiomyopathy in...

Merck’s $10B Bet Hinges on Lung Drug Patents in Verona Acquisition

July 13, 2025

Merck’s acquisition of Verona Pharma for $10 billion centers on Verona’s COPD drug, Ohtuvayre, whose main patent expired in 2020. For Merck to capitalize on the deal, secondary patents protecting...

Real-Time Monitoring Partnership Advances Viral Vector Manufacturing

July 13, 2025

Repligen Technologies and Univercells have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform into Univercells’ scale-X bioreactors to enable continuous monitoring of...

Biopharma Deal Volume Surges to $35 Billion in June 2025

July 13, 2025

Biopharma dealmaking skyrocketed in June 2025, reaching $35.07 billion, marking the highest monthly total of the year and contributing to a first-half 2025 deal value of $138.31 billion. This...

US Biotech Growth Lags While China Accelerates in 2025

July 13, 2025

Analysis shows that the U.S. biotech sector is yet to achieve significant growth momentum compared to China’s surging industry performance in 2025. Public market previews and reports from...

FDA Approvals Maintain Pace with Three New Molecular Entities in June

July 13, 2025

The FDA approved three new molecular entities (NMEs) in June 2025, contributing to a year-to-date total of 19 approvals with additional approvals already recorded in July. This steady regulatory...

Biomanufacturing Faces Talent Shortages by 2028, Experts Warn

July 13, 2025

Industry experts predict a biomanufacturing talent shortage by 2028 due to gaps in existing skills and increased technology demands. Jason Beckwith, PhD, emphasizes the need for cross-industry...

Emerging AI Tools Accelerate Vaccine and Antibody Research

July 13, 2025

Scripps Research scientists developed a microchip that rapidly maps antibody-virus interactions using minimal blood samples. This innovation provides faster and clearer insights into immune...

Chugai and Gero Collaborate on AI-Driven Age-Related Disease Targets

July 13, 2025

Chugai Pharmaceutical, a Roche subsidiary, has partnered with Singapore-based AI company Gero to identify drug targets for age-related diseases using Gero’s human data-centric platform. The...

Proteomic Advances Redefine Alzheimer’s Protein Misfolding Scope

July 13, 2025

Johns Hopkins University researchers have expanded the understanding of protein misfolding in age-related cognitive decline beyond amyloid-beta and tau. Using limited proteolysis mass spectrometry...

Real-Time Viral Vector Monitoring Boosts Biomanufacturing Efficiency

July 13, 2025

Univercells Technologies and Repligen have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform into Univercells' scale-X bioreactors. This innovation enables frequent,...

FDA Issues Complete Response Letter to Capricor on Duchenne Cell Therapy

July 13, 2025

Capricor Therapeutics received an FDA complete response letter (CRL) for deramiocel, its off-the-shelf cell therapy targeting cardiomyopathy in Duchenne muscular dystrophy (DMD). The regulator...

Merck Completes $10B Acquisition of Verona Pharma for COPD Pipeline

July 13, 2025

Merck & Co. has finalized the $10 billion acquisition of Verona Pharma, securing the rights to its lead COPD drug, Ohtuvayre. Despite the main patent’s 2020 expiry, Merck is banking on secondary...

Pfizer-Astellas Xtandi Combo Shows Survival Benefit in Early Prostate Cancer

July 13, 2025

Results from the phase 3 Embark trial demonstrate that combining Xtandi with leuprolide significantly improves overall survival in patients with non-metastatic hormone-sensitive prostate cancer...

BioEmu AI Model Accelerates Protein Dynamics Prediction

July 13, 2025

Microsoft Research AI introduced BioEmu, a generative deep learning system that rapidly emulates protein equilibrium ensembles. Published in Science, BioEmu predicts diverse protein conformations...

Intranasal Monoclonal Antibody Shows Promise Against Hay Fever and Asthma

July 13, 2025

Kazakh National Agrarian Research University scientists engineered a monoclonal antibody delivered intranasally that blocks mugwort pollen allergens, preventing hay fever and asthma symptoms in...

Biomanufacturing Faces Looming Talent Shortage by 2028

July 13, 2025

Jason Beckwith, PhD from Merrill warns a 'talent singularity' will hit biomanufacturing by 2028, with demand for skilled workers outstripping supply. The sector must adopt cross-industry...

Wacker Chemie Opens Dedicated Biotechnology Center in Munich

July 13, 2025

Wacker Chemie launched its Wacker Biotechnology Center, a multi-floor facility focused on biopharmaceutical R&D, including protein and nucleic acid production processes essential for mRNA-based...